Pasireotide (SOM230) Is Effective for the Treatment of Pancreatic Neuroendocrine Tumors (PNETs) in a Multiple Endocrine Neoplasia Type 1 (MEN1) Conditional Knockout Mouse Model

Surgery - United States
doi 10.1016/j.surg.2012.08.021
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

Elsevier BV

Related search

The Current Strategy for Managing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1

Gut and Liver
HepatologyGastroenterology
2012English

Novel MEN1 Gene Mutations in Familial Multiple Endocrine Neoplasia Type 1

Journal of Human Genetics
Genetics
1998English

Regional Lymphadenectomy Is Indicated in the Surgical Treatment of Pancreatic Neuroendocrine Tumors (PNETs)

Annals of Surgery
Surgery
2014English

An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs)

Rare Cancers and Therapy
2015English

Non-Functioning Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 1 Syndrome: Case Report

Universal Journal of Public Health
2019English

Multiple Endocrine Neoplasia Type 1

2020English

Natural Course of Small, Asymptomatic Neuroendocrine Pancreatic Tumours in Multiple Endocrine Neoplasia Type 1: An Endoscopic Ultrasound Imaging Study

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

Osteoporosis in Multiple Endocrine Neoplasia Type 1

Archives of Surgery
1999English

Unusual Presentation of Multiple Endocrine Neoplasia Type 1 in a Young Woman With a Novel Mutation of the MEN1 Gene

Journal of Human Genetics
Genetics
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy